{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:49:11Z","timestamp":1772120951741,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jaip.2019.06.003","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T04:06:20Z","timestamp":1561003580000},"page":"2804-2811","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Effect of Sublingual Immunotherapy on Airway Inflammation and Airway Wall Thickness in Allergic Asthma"],"prefix":"10.1016","volume":"7","author":[{"given":"Makoto","family":"Hoshino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Akitsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2019.06.003_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/bmj.325.7361.411","article-title":"Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey","volume":"325","author":"Zureik","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2019.06.003_bib2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1081-1206(10)61782-6","article-title":"Aspirin intolerance and allergy to house dust mites: important factors associated with development of severe asthma","volume":"92","author":"Kupczyk","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1081-1206(10)63136-5","article-title":"Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and Immunology","volume":"81","author":"Bousquet","year":"1998","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl 91","key":"10.1016\/j.jaip.2019.06.003_bib4","first-page":"1","article-title":"Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009","volume":"64","author":"Canonica","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.06.003_bib5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaci.2010.06.047","article-title":"Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision","volume":"126","author":"Brozek","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib7","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jaci.2014.03.019","article-title":"Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial","volume":"134","author":"Mosbech","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib8","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.rmed.2014.07.017","article-title":"SQ HDM SLIT-tablet (ALK) in treatment of asthma\u2014post hoc results from a randomised trial","volume":"108","author":"de Blay","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2019.06.003_bib9","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1001\/jama.2016.3964","article-title":"Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma","volume":"315","author":"Virchow","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2019.06.003_bib10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40413-016-0132-1","article-title":"Effect of adjuvanted and standard sublingual immunotherapy on respiratory function in pure rhinitis due to house dust mite over a 5-year period","volume":"10","author":"Marogna","year":"2017","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2019.06.003_bib11","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.06.003_bib12","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1164\/ajrccm.162.4.9909044","article-title":"Airway wall thickness in asthma assessed by computed tomography. Relation to clinical indices","volume":"62","author":"Niimi","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.06.003_bib13","first-page":"154","article-title":"Tolerability during double-blind randomized phase I trials with the house dust mite allergy immunotherapy tablet in adults and children","volume":"24","author":"Corzo","year":"2014","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib14","series-title":"Guidelines for pulmonary function tests. Spirometry, flow volume curve, diffusion capacity of the lung","year":"2004"},{"key":"10.1016\/j.jaip.2019.06.003_bib15","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care"},{"key":"10.1016\/j.jaip.2019.06.003_bib16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.rmed.2009.12.005","article-title":"Correlation between airflow limitation and airway dimensions assessed by multidetector CT in asthma","volume":"104","author":"Hoshino","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2019.06.003_bib17","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1440-1843.2012.02130.x","article-title":"Effects of budesonide\/formoterol combination versus budesonide on airway dimensions in asthma","volume":"7","author":"Hoshino","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2019.06.003_bib18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/thx.47.2.76","article-title":"Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials","volume":"47","author":"Juniper","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2019.06.003_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0091-6749(99)70380-5","article-title":"Validation of the standardized version of the Rhinoconjunctivitis Quality of Life Questionnaire","volume":"104","author":"Juniper","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","article-title":"SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial","volume":"129","author":"Durham","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"Suppl 104","key":"10.1016\/j.jaip.2019.06.003_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/all.13355","article-title":"Perspectives in allergen immunotherapy: 2017 and beyond","volume":"73","author":"Pfaar","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.06.003_bib22","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jaci.2015.07.038","article-title":"Allergy immunotherapy for allergic rhinitis effectively prevents asthma: results from a large retrospective cohort study","volume":"136","author":"Schmitt","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/all.13213","article-title":"Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: a retrospective, real-world database analysis","volume":"73","author":"Zielen","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.06.003_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaci.2017.06.014","article-title":"Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy","volume":"141","author":"Valovirta","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib25","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1067\/mai.2001.118891","article-title":"Allergic rhinitis and its impact on asthma. Aria Workshop Group; World Health Organization","volume":"108","author":"Bousquet","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1939-4551-7-6","article-title":"Sublingual immunotherapy: World Allergy Organization position paper 2013 update","volume":"7","author":"Canonica","year":"2014","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2019.06.003_bib27","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1164\/ajrccm.163.7.2009041","article-title":"Exhaled markers of pulmonary disease","volume":"163","author":"Kharitonov","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.06.003_bib28","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1164\/ajrccm.164.8.2101145","article-title":"Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone","volume":"164","author":"Payne","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2019.06.003_bib29","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jaci.2005.02.031","article-title":"Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study","volume":"115","author":"Marogna","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib30","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1111\/all.13208","article-title":"Allergen immunotherapy for allergic asthma: a systematic review and meta-analysis","volume":"72","author":"Dhami","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2019.06.003_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12948-017-0064-5","article-title":"Effects of specific allergen immunotherapy on biological markers and clinical parameters in asthmatic children: a controlled-real life study","volume":"15","author":"Djuric-Filipovic","year":"2017","journal-title":"Clin Mol Allergy"},{"key":"10.1016\/j.jaip.2019.06.003_bib32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1136\/thorax.57.3.242","article-title":"Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma","volume":"57","author":"Kasahara","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2019.06.003_bib33","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaci.2013.12.1088","article-title":"Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens","volume":"133","author":"Akdis","year":"2014","journal-title":"J\u00a0Allergy Clinical Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib34","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nri1934","article-title":"Immunological mechanisms of allergen-specific immunotherapy","volume":"6","author":"Larch\u00e9","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib35","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0091-6749(96)70205-1","article-title":"Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma","volume":"97","author":"Durham","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib36","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1365-2222.2004.01869.x","article-title":"Bacillus Calmette-Gu\u00e9rin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy","volume":"34","author":"Arikan","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.06.003_bib37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2222.2006.02429.x","article-title":"Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production","volume":"36","author":"Cosmi","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2019.06.003_bib38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000446155","article-title":"House dust mite-specific sublingual immunotherapy prevents the development of allergic inflammation in a mouse model of experimental asthma","volume":"170","author":"Hagner","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jaci.2015.04.047","article-title":"International consensus on allergy immunotherapy","volume":"136","author":"Jutel","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib40","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jaci.2015.06.036","article-title":"Effective treatment of house dust mite\u2013induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: results from a randomized, double-blind, placebo-controlled phase III trial","volume":"137","author":"Demoly","year":"2016","journal-title":"J\u00a0Allergy Clinical Immunol"},{"key":"10.1016\/j.jaip.2019.06.003_bib41","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.jaci.2016.09.043","article-title":"Efficacy and safety of the SQ house dust mite sublingual immunotherapy tablet in Japanese adults and adolescents with house dust mite-induced allergic rhinitis","volume":"139","author":"Okubo","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819305525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219819305525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:20:07Z","timestamp":1761974407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219819305525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2213219819305525"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2019.06.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736033155.793563507","asserted-by":"object"}]},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Sublingual Immunotherapy on Airway Inflammation and Airway Wall Thickness in Allergic Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2019.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}